Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 7 , Pages 637-646 , July 2010

Access to Treatment for Adolescents With Substance Use and Co-Occurring Disorders: Challenges and Opportunities

  • Stacy Sterling, M.P.H., M.S.W.

      Affiliations

    • Kaiser Permanente
    • Corresponding Author InformationCorrespondence to Dr. Stacy Sterling, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, 3rd Floor, Oakland, CA 94612-2403
    • ,
  • Constance Weisner, Dr.P.H., M.S.W.

      Affiliations

    • Kaiser Permanente
    • University of California
    • ,
  • Agatha Hinman, B.A.

      Affiliations

    • Kaiser Permanente
    • ,
  • Sujaya Parthasarathy, Ph.D.

      Affiliations

    • Kaiser Permanente

,Accepted 31 March 2010.

References 

  1. Brindis C, Park MJ, Ozer EM, et al. Adolescents' access to health services and clinical preventive health care: crossing the great divide. Pediatr Ann. 2002;31:575–581
  2. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH Report: Trends in Substance Use, Dependence or Abuse, and Treatment among Adolescents: 2002 to 2007 (December 4, 2008). Rockville, MD, 2008 http://www.oas.samhsa.gov/2k8/youthTrends/youthTrends.htm
  3. Johnston LD, O'Malley PM, Bachman JG, et al. Teen marijuana use tilts up, while some drugs decline in use (University of Michigan News Service). http://www.monitoringthefuture.orgAccessed Mar 17, 2010
  4. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the Future national results on adolescent drug use: overview of key findings, 2008 NIH Publication No. 09-7401. Bethesda, MD: National Institute on Drug Abuse; May, 2009;
  5. Centers for Disease Control and Prevention. Cigarette use among high school students—United States, 1991-2007. Morbidity and Mortality Weekly Review (MMWR). 2008;57:689–691
  6. MetLife Foundation, The Partnership for a Drug-Free America. 2009 Parents and Teens Attitude Tracking Study Report; Mar 2, 2010. http://www.drugfree.org/Files/PATS_Full_Report_2009_PDF
  7. Ammon L, Sterling S, Mertens J, et al. Adolescents in private chemical dependency programs: who are most at risk for HIV?. J Subst Abuse Treat. 2005;29:39–45
  8. Substance Abuse and Mental Health Services Administration. SAMHSA Report to Congress - Nov 2002 (The prevention and treatment of co-occurring substance abuse disorders and mental disorders). Rockville, MD: Substance Abuse and Mental Health Services Administration, 2002 http://www.samhsa.gov/reports/congress2002/CoOccurringRpt.pdf
  9. Wu LT, Ringwalt CL. Use of alcohol treatment and mental health services among adolescents with alcohol use disorders. Psychiatr Serv. 2006;57:84–92
  10. Sterling S, Kohn CS, Lu Y, et al. Pathways to chemical dependency treatment for adolescents in an HMO. J Psychoactive Drugs. 2004;36:439–453
  11. Mertens JR, Flisher AJ, Fleming MF, et al. Medical conditions of adolescents in alcohol and drug treatment: comparison with matched controls. J Adolesc Health. 2007;40:173–179
  12. Parthasarathy S, Weisner C. Health care services use by adolescents with intakes into an outpatient alcohol and drug treatment program. Am J Addict. 2006;15(Suppl):113–121
  13. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH Report: Adolescent Mental Health: Service Settings and Reasons for Receiving Care (February 19, 2009) (Rockville, MD, 2009). http://www.oas.samhsa.gov/2k9/youthMHcare/youthMHcare.htm
  14. Chan YF, Dennis ML, Funk RR. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat. 2008;34:14–24
  15. Grella CE, Hser YI, Joshi V, et al. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis. 2001;189:384–392
  16. Sterling S, Weisner C. Chemical dependency and psychiatric services for adolescents in private managed care: implications for outcomes. Alcohol Clin Exp Res. 2005;25:801–809
  17. In:  Mee-Lee D,  Shulman GD,  Fishman M, et al. editor. Patient Placement Criteria for the Treatment of Substance-Related Disorders, Second Edition-Revised (ASAM-PPC-2R). Chevy Chase, MD: American Society of Addiction Medicine; 2001;
  18. Fishman M. Placement criteria and strategies for adolescent treatment matching. In:  Graham AW,  Schultz TK,  Mayo-Smith M,  Ries RK,  Wilford BB editor. Principles of Addiction Medicine. 3rd ed.. Chevy Chase, MD: American Society of Addiction Medicine; 2003;p. 1559–1572
  19. Windle M, Spear LP, Fuligni AJ, et al. Transitions into underage and problem drinking: developmental processes and mechanisms between 10 and 15 years of age. Pediatrics. 2008;121(Suppl 4):S273–S289
  20. American Academy of Pediatrics. Committee on Child Health Financing (Guiding principles for managed care arrangements for the health care of newborns, infants, children, adolescents, and young adults). Pediatrics. 2000;105:132–135
  21. Kapphahn CJ, Morreale MC, Rickert VI, et al. Financing mental health services for adolescents: a position paper of the Society for Adolescent Medicine. J Adolesc Health. 2006;39:456–458
  22. Hawkins EH. A tale of two systems: co-occurring mental health and substance abuse disorders treatment for adolescents. Annu Rev Psychol. 2009;60:197–227
  23. Lu C, Frank RG, McGuire TG. Demand response of mental health services to cost sharing under managed care. J Ment Health Policy Econ. 2008;11:113–125
  24. Libby AM, Riggs PD. Integrated substance use and mental health treatment for adolescents: aligning organizational and financial incentives. J Child Adolesc Psychopharmacol. 2005;15:826–834
  25. DeGruy FV. Mental health care in the primary setting. In:  Donaldson M,  Yordy K,  Kohr K,  Vanselow N editor. Primary Care: America's Health in a New Era. Washington, DC: National Academy Press; 1996;p. 285–311
  26. Grazier KL, Eselius LL. Mental health carve-outs: effects and implications. Med Care Res Rev. 1999;56(Suppl 2):37–59
  27. Huskamp HA. How a managed behavioral health care carve-out plan affected spending for episodes of treatment. Psychiatr Serv. 1998;49:1559–1562
  28. Institute of Medicine. Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series. Washington, DC: National Academies Press; 2006;
  29. Frank RG, Garfield RL. Managed behavioral health care carve-outs: past performance and future prospects. Annu Rev Public Health. 2007;28:303–320
  30. Drake RE, Mueser KT, Clark RE, et al. The course, treatment, and outcome of substance disorder in persons with severe mental illness. Am J Orthopsychiatry. 1996;66:42–51
  31. Mercer CC, Mueser KT, Drake RE. Organizational guidelines for dual disorders programs. Psychiatr Q. 1998;69:145–168
  32. Levit KR, Kassed CA, Coffey RM, et al. Projections of National Expenditures for Mental Health Services and Substance Abuse Treatment, 2004-2014. SAMHSA Publication No. SMA 08-4326 (Rockville, MD: Substance Abuse and Mental Health Services Administration, 2008). http://csat.samhsa.gov/IDBSE/spendEst/reports/MHSA_Est_Spending2003_2014.pdf
  33. Newacheck PW, Park MJ, Brindis CD, et al. Trends in private and public health insurance for adolescents. J Am Med Assoc. 2004;291:1231–1237
  34. Drake RE, O'Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat. 2008;34:123–138
  35. Managed Care Initiative Panel on Co-occurring Disorders. Co-occurring Psychiatric and Substance Disorders in Managed Care Systems: Standards of Care, Practice Guidelines, Workforce Competencies, and Training Curricula. Rockville, MD: Center for Mental Health Services; Jan, 1998;
  36. Burnam MA, Watkins KE. Substance abuse with mental disorders: specialized public systems and integrated care. Health Aff (Millwood). 2006;25:648–658
  37. Hutchinson AB, Foster EM. The effect of Medicaid managed care on mental health care for children: a review of the literature. Ment Health Serv Res. 2003;5:39–54
  38. McCarty D, Argeriou M. The Iowa Managed Substance Abuse Care Plan: access, utilization, and expenditures for Medicaid recipients. J Behav Health Serv Res. 2003;30:18–25
  39. Carlson MJ, Gabriel RM, Deck DD, et al. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington. Med Care Res Rev. 2005;62:320–338
  40. Timko C, Dixon K, Moos RH. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems. Ment Health Serv Res. 2005;7:229–242
  41. Martin G, Copeland J. The Adolescent Cannabis Check-Up: randomized trial of a brief intervention for young cannabis users. J Subst Abuse Treat. 2008;34:407–414
  42. Knight JR, Sherritt L, Van Hook S, et al. Motivational interviewing for adolescent substance use: a pilot study. J Adolesc Health. 2005;37:167–169
  43. American Academy of Pediatrics. Periodic survey of fellows: 45% of Fellows routinely screen for alcohol use (American Academy of Pediatrics, Division of Child Health Research). http://aapnews.aappublications.org/cgi/content/short/14/10/12002;Accessed April 6, 2009
  44. Bethell C, Klein J, Peck C. Assessing health system provision of adolescent preventive services: the Young Adult Health Care Survey. Med Care. 2001;39:478–490
  45. Wilson CR, Sherritt L, Gates E, et al. Are clinical impressions of adolescent substance use accurate?. Pediatrics. 2004;114:e536–e540
  46. Blumenthal D, Gokhale M, Campbell EG, et al. Preparedness for clinical practice: reports of graduating residents at academic health centers. J Am Med Assoc. 2001;286:1027–1034
  47. Friedmann PD, McCullough D, Chin MH, et al. Screening and intervention for alcohol problems (A national survey of primary care physicians and psychiatrists). J Gen Intern Med. 2000;15:84–91
  48. Gassman RA. Medical specialization, profession, and mediating beliefs that predict stated likelihood of alcohol screening and brief intervention: targeting educational interventions. Subst Abus. 2003;24:141–156
  49. Renner JA. How to train residents to identify and treat dual diagnosis patients. Biol Psychiatry. 2004;56:810–816
  50. Substance Abuse and Mental Health Services Administration. SAMHSA to provide $3.75 million to train medical residents in SBIRT techniques. http://www.samhsa.gov/newsroom/advisories/0803041505.aspxAccessed Jan 13, 2010
  51. Thomas CP, Wallack SS, Lee S, et al. Research to practice: adoption of naltrexone in alcoholism treatment. J Subst Abuse Treat. 2003;24:1–11
  52. Woody GE, Poole SA, Subramaniam G, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. J Am Med Assoc. 2008;300:2003–2011
  53. Riggs PD, Mikulich-Gilbertson SK, Davies RD, et al. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med. 2007;161:1026–1034
  54. Electronic Code of Federal Regulations (e-CFR). TITLE 42—Public Health, Chapter I—Public Health Service, Department of Health And Human Services, Subchapter A—General Provisions, Part 2—Confidentiality of Alcohol and Drug Abuse Patient RecordsGovernment Printing Office (Government Printing Office). http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&tpl=/ecfrbrowse/Title42/42cfr2_main_02.tpl.Published 2009. Updated Oct 19, 2009. Accessed Jan 11, 2010
  55. Sterling S, Hinman A, Kohn CS, et al. Pathways to substance abuse treatment for adolescents: implications for policy (Provider interviews summary). [Report to RWJF, I.D. #037863] Oakland, CA: Kaiser Permanente Northern California Division of Research; Jul 22, 2002;
  56. Hofmann AD. A rational policy toward consent and confidentiality in adolescent health care. J Adolesc Health Care. 1980;1:9–17
  57. French MT. Drug Abuse Treatment Cost Analysis Program (DATCAP) [computer program] (Program version). 8th ed.. Coral Gables, FL: University of Miami; 2003;
  58. French MT, Roebuck MC, Dennis ML, et al. Outpatient marijuana treatment for adolescents (Economic evaluation of a multisite field experiment). Eval Rev. 2003;27:421–459
  59. French MT, Roebuck MC, Dennis ML, et al. The economic cost of outpatient marijuana treatment for adolescents: findings from a multi-site field experiment. 1 Addiction. 2002;97(Suppl):84–97
  60. Zavala SK, French MT, Henderson CE, et al. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments. J Subst Abuse Treat. 2005;29:191–205
  61. Sindelar JL, Jofre-Bonet M, French MT, et al. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug Alcohol Depend. 2004;73:41–50
  62. McCollister KE, French MT. The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings. Addiction. 2003;98:1647–1659
  63. Balsa AI, Homer JF, French MT, et al. Substance use, education, employment, and criminal activity outcomes of adolescents in outpatient chemical dependency programs. J Behav Health Serv Res. 2009;36:75–95
  64. Roebuck MC, French MT, McLellan AT. DATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat. 2003;25:51–57
  65. French MT, Zavala SK, McCollister KE, et al. Cost-effectiveness analysis of four interventions for adolescents with a substance use disorder. J Subst Abuse Treat. 2008;34:272–281
  66. American Society of Addiction Medicine (ASAM). Public policy statement on parity in publicly funded health insurance benefits for treatment of addiction. Chevy Chase, MD: American Society of Addiction Medicine; 2009;
  67. Centers for Medicare & Medicaid Services, U. S. Department of Health & Human Services. The Mental Health Parity Act. Updated Dec 4, 2009 http://www.cms.hhs.gov/healthinsreformforconsume/04_thementalhealthparityact.aspAccessed Jan 11, 2010
  68. Barry CL, Frank RG, McGuire TG. The costs of mental health parity: still an impediment?. Health Aff (Millwood). 2006;25:623–634
  69. Azrin ST, Huskamp HA, Azzone V, et al. Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics. 2007;119:e452–e459
  70. Current Procedural Terminology, American Medical Association. HEDIS 2009 Summary Table of Measures, Product Lines and Changes. http://www.ncqa.org/Portals/0/HEDISQM/HEDIS2009/2009_Measures.pdf2008;Accessed Jan 13, 2010
  71. Rosenthal MB, Frank RG. What is the empirical basis for paying for quality in health care?. Med Care Res Rev. 2006;63:135–157
  72. Bremer RW, Scholle SH, Keyser D, et al. Pay for performance in behavioral health. Psychiatr Serv. 2008;59:1419–1429
  73. McLellan AT, Kemp J, Brooks A, et al. Improving public addiction treatment through performance contracting: the Delaware experiment. Health Policy. 2008;87:296–308
  74. Brucker D. Access and Retention in Treatment: Paying for Performance in Maine. Addiction Health Services Research Conference, San Francisco, CA, Oct 28-30, 2009.
  75. In:  Edmunds M,  Frank R,  Hogan M, et al. editor. Managing Managed Care: Quality Improvement in Behavioral Health. Washington, DC: National Academy Press; 1997;
  76. Chi FW, Sterling S, Weisner C. Adolescents with co-occurring substance use and mental conditions in a private managed care health plan: prevalence, patient characteristics, and treatment initiation and engagement. Am J Addict. 2006;15(Suppl):67–79
  77. Collins SR, Schoen C, Kriss JL, et al. Rite of passage? (Why young adults become uninsured and how new policies can help). Issue Brief (Commonw Fund). 2006;20:1–14

 This article can be used to obtain continuing medical education (CME) category 1 credit at jaacap.org.

 Paula De Graffenreid Riggs, M.D., and Catherine A. Martin, M.D., served as assistant editors for this article.

 This research was supported by the National Institute on Alcohol Abuse and Alcoholism.

 Disclosure: Ms. Sterling, Drs. Weisner and Parthasarathy, and Ms. Hinman report no biomedical financial interests or potential conflicts of interest.

PII: S0890-8567(10)00319-9

doi: 10.1016/j.jaac.2010.03.019

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 7 , Pages 637-646 , July 2010

Article Tools